Literature DB >> 18567223

Extended parallel process model and H5N1 influenza virus.

Wanda Siu1.   

Abstract

This study integrated the Extended Parallel Process Model and forewarning cues to assess the promotion of preventive measures against the H5N1 influenza virus, a significant health threat that affects Asia, Europe, and the USA. There are two types of forewarning, (1) telling the audience that they will hear messages intended to persuade them and (2) telling the audience the topic and stance of the impending persuasive message. Analysis of ratings by 265 undergraduates indicated that forewarnings of the topic and stance of a promotional message on the H5N1 virus facilitated elaboration of coping-related thoughts which enhance perceived self-efficacy and a stronger behavioral intention to combat H5N1. Conversely, the elaboration of danger-related thoughts evoked some fear but enhanced source perception.

Entities:  

Mesh:

Year:  2008        PMID: 18567223     DOI: 10.2466/pr0.102.2.539-550

Source DB:  PubMed          Journal:  Psychol Rep        ISSN: 0033-2941


  4 in total

1.  Behavioural intentions in response to an influenza pandemic.

Authors:  Gerjo Kok; Ruud Jonkers; Roger Gelissen; Ree Meertens; Herman Schaalma; Onno de Zwart
Journal:  BMC Public Health       Date:  2010-03-30       Impact factor: 3.295

2.  Application of Behavioral Theories to Disaster and Emergency Health Preparedness: A Systematic Review.

Authors:  Luche Tadesse Ejeta; Ali Ardalan; Douglas Paton
Journal:  PLoS Curr       Date:  2015-07-01

3.  Social Media Use, Self-Efficacy, Perceived Threat, and Preventive Behavior in Times of COVID-19: Results of a Cross-Sectional Study in Pakistan.

Authors:  Qaisar Khalid Mahmood; Sara Rizvi Jafree; Sahifa Mukhtar; Florian Fischer
Journal:  Front Psychol       Date:  2021-06-17

4.  A Threat- and Efficacy-Based Framework to Understand Confidence in Vaccines among the Public Health Workforce.

Authors:  Daniel J Barnett; Nicole A Errett; Lainie Rutkow
Journal:  Vaccines (Basel)       Date:  2013-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.